CIK 78003
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 84.56% | 15 |
| Health Care Providers & Services | 13.13% | 1 |
| Unclassified | 2.31% | 2 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | ORIC | Oric Pharmaceuticals, Inc. | Health Care | 24.14% |
| 2 | ALLO | Allogene Therapeutics, Inc. | Health Care | 20.85% |
| 3 | ARVN | ARVINAS, INC. | Health Care | 14.63% |
| 4 | CELC | Celcuity Inc. | Health Care | 13.13% |
| 5 | ZURA | Zura Bio Ltd | Health Care | 7.05% |
| 6 | WVE | Wave Life Sciences Ltd. | Health Care | 5.00% |
| 7 | PYXS | Pyxis Oncology, Inc. | Health Care | 3.86% |
| 8 | CRBU | Caribou Biosciences, Inc. | Health Care | 3.50% |
| 9 | SPRO | SPERO THERAPEUTICS INC | Unclassified | 2.31% |
| 10 | BHVN | Biohaven Ltd. | Health Care | 1.77% |
16/18 names classified · sector 97.7% of weight · industry 97.7% · mkt cap 97.3%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 97.7% of the book is sector-classified (unclassified names shown, never dropped).
Only 0% of book weight classified — the grid is NOT representative of the whole book.
Classified: 0.3% of book weight (1/18 names) · unclassified 99.7%: ORIC, ALLO, ARVN, CELC, ZURA, WVE, PYXS, CRBU, SPRO, BHVN +7 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | ORICORIC PHARMACEUTICALS INC | 4,780,401 | $58M | 24.1% | TRIM −11% |
| 2 | ALLOALLOGENE THERAPEUTICS INC | 22,032,040 | $50M | 20.9% | HOLD |
| 3 | ARVNARVINAS INC | 3,457,815 | $35M | 14.6% | HOLD |
| 4 | CELCCELCUITY INC | 295,652 | $31M | 13.1% | TRIM −15% |
| 5 | ZURAZURA BIO LTD | 2,838,913 | $17M | 7.1% | TRIM −4% |
| 6 | WVEWAVE LIFE SCIENCES LTD | 1,875,000 | $12M | 5.0% | HOLD |
| 7 | PYXSPYXIS ONCOLOGY INC | 7,032,770 | $9M | 3.9% | HOLD |
| 8 | CRBUCARIBOU BIOSCIENCES INC | 4,690,431 | $8M | 3.5% | HOLD |
| 9 | SPROSPERO THERAPEUTICS INC | 2,362,348 | $6M | 2.3% | HOLD |
| 10 | BHVNBIOHAVEN LTD | 505,645 | $4M | 1.8% | HOLD |
| 11 | CRDFCARDIFF ONCOLOGY INC | 2,411,575 | $4M | 1.6% | HOLD |
| 12 | ZNTLZENTALIS PHARMACEUTICALS INC | 953,834 | $2M | 0.8% | HOLD |
| 13 | NXTCNEXTCURE INC | 153,354 | $2M | 0.6% | TRIM −3% |
| 14 | AGMBAGOMAB THERAPEUTICS NV | 75,000 | $813,750 | 0.3% | NEW |
| 15 | QTTBQ32 BIO INC | 101,618 | $736,731 | 0.3% | TRIM −63% |
| 16 | BOLTBOLT BIOTHERAPEUTICS INC | 31,305 | $137,116 | 0.1% | HOLD |
| 17 | DNAGINKGO BIOWORKS HOLDINGS INC | 2,928 | $17,363 | 0.0% | HOLD |
| 18 | SENSEONICS HLDGS INC | 2,171 | $14,242 | 0.0% | HOLD |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| ORICORIC PHARMACEUTICALS INC | 5.4M | 5.4M | 5.4M | 5.4M | 5.4M | 4.8M | $58M |
| ALLOALLOGENE THERAPEUTICS INC | 22.0M | 22.0M | 22.0M | 22.0M | 22.0M | 22.0M | $50M |
| ARVNARVINAS INC | 3.5M | 3.5M | 3.5M | 3.5M | 3.5M | 3.5M | $35M |
| CELCCELCUITY INC | 349K | 349K | 349K | 349K | 349K | 296K | $31M |
| ZURAZURA BIO LTD | 3.0M | 3.0M | 3.0M | 3.0M | 3.0M | 2.8M | $17M |
| WVEWAVE LIFE SCIENCES LTD | 1.9M | 1.9M | 1.9M | 1.9M | 1.9M | 1.9M | $12M |
| PYXSPYXIS ONCOLOGY INC | 7.0M | 7.0M | 7.0M | 7.0M | 7.0M | 7.0M | $9M |
| CRBUCARIBOU BIOSCIENCES INC | 4.7M | 4.7M | 4.7M | 4.7M | 4.7M | 4.7M | $8M |
| SPROSPERO THERAPEUTICS INC | 2.4M | 2.4M | 2.4M | 2.4M | 2.4M | 2.4M | $6M |
| BHVNBIOHAVEN LTD | 506K | 506K | 506K | 506K | 506K | 506K | $4M |
| CRDFCARDIFF ONCOLOGY INC | 2.4M | 2.4M | 2.4M | 2.4M | 2.4M | 2.4M | $4M |
| ZNTLZENTALIS PHARMACEUTICALS INC | 954K | 954K | 954K | 954K | 954K | 954K | $2M |
| NXTCNEXTCURE INC | — | — | — | 158K | 158K | 153K | $2M |
| AGMBAGOMAB THERAPEUTICS NV | — | — | — | — | — | 75K | $813,750 |
| QTTBQ32 BIO INC | 278K | 278K | 278K | 278K | 278K | 102K | $736,731 |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
